Preclinical evaluation of a novel AAV-GDF5 vector in a 6-OHDA model of Parkinson’s disease and evaluation of the effect of 6-OHDA on the expression of HDACs

Files in this item

This item appears in the following Collection(s)

© 2020, Sarah Elizabeth Shanahan. Except where otherwise noted, this item's license is described as © 2020, Sarah Elizabeth Shanahan.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement